- Home
- NEWT vs ABSI Comparison
NEWT vs ABSI Comparison
Compare NEWT & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEWT
- ABSI
- Stock Information
- Founded
- NEWT 1998
- ABSI 2011
- Country
- NEWT United States
- ABSI United States
- Employees
- NEWT N/A
- ABSI N/A
- Industry
- NEWT Major Banks
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- NEWT Finance
- ABSI Health Care
- Exchange
- NEWT Nasdaq
- ABSI Nasdaq
- Market Cap
- NEWT 294.8M
- ABSI 338.0M
- IPO Year
- NEWT N/A
- ABSI 2021
- Fundamental
- Price
- NEWT $11.66
- ABSI $2.84
- Analyst Decision
- NEWT Hold
- ABSI Strong Buy
- Analyst Count
- NEWT 4
- ABSI 5
- Target Price
- NEWT $13.00
- ABSI $8.28
- AVG Volume (30 Days)
- NEWT 249.9K
- ABSI 6.7M
- Earning Date
- NEWT 07-28-2025
- ABSI 08-12-2025
- Dividend Yield
- NEWT 6.52%
- ABSI N/A
- EPS Growth
- NEWT 27.62
- ABSI N/A
- EPS
- NEWT 1.92
- ABSI N/A
- Revenue
- NEWT $352,584,000.00
- ABSI $4,815,000.00
- Revenue This Year
- NEWT N/A
- ABSI $74.53
- Revenue Next Year
- NEWT $13.51
- ABSI $296.01
- P/E Ratio
- NEWT $6.05
- ABSI N/A
- Revenue Growth
- NEWT 23.06
- ABSI N/A
- 52 Week Low
- NEWT $9.12
- ABSI $2.01
- 52 Week High
- NEWT $15.49
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- NEWT 54.84
- ABSI 46.28
- Support Level
- NEWT $11.05
- ABSI $2.83
- Resistance Level
- NEWT $11.44
- ABSI $3.04
- Average True Range (ATR)
- NEWT 0.34
- ABSI 0.21
- MACD
- NEWT -0.03
- ABSI -0.03
- Stochastic Oscillator
- NEWT 55.45
- ABSI 21.74
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.